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Abstract
© 2017 Khaiboullina, Mendelevich, Shigapova, Shagimardanova, Gazizova, Nikitin, Martynova,
Davidyuk,  Bogdanov,  Gusev,  van den Maagdenberg,  Giniatullin  and Rizvanov.  Background:
Immune mechanisms recently emerged as important contributors to migraine pathology with
cytokines affecting neuronal excitation. Therefore, elucidating the profile of cytokines activated
in various forms of migraine, including those with a known genetic cause, can help in diagnostic
and therapeutic approaches. Methods: Here we (i) performed exome sequencing to identify the
causal gene mutation and (ii) measured, using Bio-Plex technology, 22 cytokines in serum of
patients with familial migraine (two with hemiplegic migraine and two with migraine with aura)
from a Russian family that ethnically belongs to the Tatar population. MRI scanning was used to
assess cerebellar atrophy associated with migraine in mutation carriers. Results: Whole-exome
sequencing revealed the R583Q missense mutation in the CACNA1A gene in the two patients
with hemiplegic migraine and cerebellar ataxia with atrophy, confirming a FHM1 disorder. Two
further patients did not have the mutation and suffered from migraine with aura. Elevated
serum levels of pro-inflammatory and pro-nociceptive IL-6 and IL-18 were found in all  four
patients (compared to a reference panel), whereas pro-apoptotic SCGF-β and TRAIL were higher
only in the patients with the FHM1 mutation. Also, cytokines CXCL1, HGF, LIF, and MIF were
found particularly high in the two mutation carriers, suggesting a possible role of vascular
impairment and neuroinflammation in disease pathogenesis. Notably, some “algesic” cytokines,
such as β-NGF and TNFβ, remained unchanged or even were down-regulated. Conclusion: We
present a detailed genetic, neurological, and biochemical characterization of a small Russian
FHM1 family and revealed evidence for higher levels of specific cytokines in migraine patients
that support migraine-associated neuroinflammation in the pathology of migraine.
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